BioLargo, Inc. installed its patented Aqueous Electrostatic Concentrator (AEC) PFAS treatment system at the Lake Stockholm municipal water facility in New Jersey, marking the first municipal deployment of the technology.
The AEC system removes both long‑ and short‑chain PFAS to non‑detect levels while consuming roughly 90% less energy than conventional granular activated carbon or ion‑exchange methods, and it generates significantly less waste. These advantages position the system as a compelling alternative for municipalities facing tightening PFAS regulations.
The installation is a strategic milestone for BioLargo’s commercialization strategy. It demonstrates that the company’s technology can be scaled to a municipal water treatment plant, opening the door to future contracts across the United States as regulators push for stricter PFAS limits.
CEO Dennis Calvert said the project “confirms the effectiveness of our AEC technology in a real‑world municipal setting and underscores our commitment to delivering safe drinking water.” Tonya Chandler, president of BioLargo Equipment, Solutions and Technologies, added that the plant will be monitored closely to validate long‑term performance and to refine the system for broader deployment.
The PFAS treatment market is expanding under new EPA and state regulations, and BioLargo’s energy‑efficient, low‑waste solution gives it a competitive edge over traditional methods. The company’s broader portfolio—including wound‑care, battery‑energy storage, and air‑quality control—provides diversification, but the PFAS platform remains a key growth driver.
Financially, BioLargo has a healthy cash balance but has faced profitability challenges in recent quarters, with an Altman Z‑score in the distress zone. The municipal installation, however, signals progress toward revenue growth and operational scale, which management expects to translate into improved margins as the technology is adopted more widely.
The content on EveryTicker is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.